Similar articles

• The role of induced sputum in amiodarone-associated interstitial lung diseases.

  Fireman E, Topilsky I, Viskin S, Priel IE. Fireman E, et al. Cardiology. 2007;108(4):223-7. doi: 10.1159/000096782. Epub 2006 Nov 7. Cardiology. 2007. PMID: 17095870 Clinical Trial.
• A 73-year-old man with interstitial lung disease due to dronedarone.

  Hernández Voth AR, Catalán JS, Benavides Mañas PD, Avila Martínez RJ, Peñalver Paolini CL, Díaz de Atauri Rodríguez MJ. Hernández Voth AR, et al. Am J Respir Crit Care Med. 2012 Jul 15;186(2):201-2. doi: 10.1164/ajrccm.186.2.201. Am J Respir Crit Care Med. 2012. PMID: 22798421 No abstract available.
• [Spontaneous remission of an amiodarone-induced pulmonary lesion].

  Müller M, Schima W, Weissel M. Müller M, et al. Wien Klin Wochenschr. 1997 Nov 28;109(22):887-9. Wien Klin Wochenschr. 1997. PMID: 9476338 German.
• A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia.

  Cappannoli L, Telesca A, Scacciavillani R, Petrolati E, Smargiassi A, Rabini A, Massetti M, Crea F, Aspromonte N. Cappannoli L, et al. Future Cardiol. 2021 Sep;17(6):991-997. doi: 10.2217/fca-2020-0168. Epub 2020 Dec 17. Future Cardiol. 2021. PMID: 33331164 Free PMC article. Review.
• [Drug-induced lung diseases].

  Itoh Y, Sendo T, Oishi R. Itoh Y, et al. Nihon Yakurigaku Zasshi. 2006 Jun;127(6):425-32. doi: 10.1254/fpj.127.425. Nihon Yakurigaku Zasshi. 2006. PMID: 16880691 Review. Japanese. No abstract available.